RETRACTED: Overexpressed miR-106b-5p promotes epithelial-mesenchymal transition in endometriosis by targeting PTEN
article
OA: hybrid
CC0
RETRACTED
⤵ 2 in-corpus citations
Retraction notice. Marked retracted by OpenAlex; see publisher for the formal retraction notice.
AI-generated summary
This study found that elevated miR-106b-5p in endometriosis promotes proliferation, migration, and EMT in human endometrial stromal cells by targeting PTEN.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The miRNA miR-106b-5p expression is elevated in endometriotic lesions. This study aimed to detect miR-106b-5p expression in human endometrial stromal cells and explore the molecular mechanisms regulating proliferation, migration, and epithelial-mesenchymal transition (EMT) of these cells. Cell proliferation, migration, and EMT were compared after miR-106b-5p upregulation. The downstream target of miR-106b-5p was verified using bioinformatic, luciferase reporter, and rescue assays. The relationship between miR-106b-5p and the target genes was also analyzed. Results showed that the expression of miR-106b-5p in endometriotic lesions was higher than that in non-lesion tissues. Furthermore, upregulation of miR-106b-5p promoted the proliferation, migration, and EMT of human endometrial stromal cells. Additionally, phosphatase and tensin homolog ten (PTEN) was found to be negatively correlated with miR-106b-5p expression. Low expression levels of PTEN were significantly correlated with cell proliferation, migration, and EMT. High PTEN expression could rescue the effect of miR-106b-5p on cell capacity. In conclusion, miR-106b-5p modified human endometrial stromal cell function by sponging PTEN. These findings indicate that inhibition of miR-106b-5p may be an effective therapeutic strategy for endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Aberrant PTEN expression in response to progesterone reduces endometriotic stromal cell apoptosis via openalex
- Aromatase inhibitor regulates let-7 expression and let-7f–induced cell migration in endometrial cells from women with endometriosis via openalex
- Endometriosis and Infertility via openalex
- Endometriosis and ovarian cancer risk, an epigenetic connection via openalex
- Endometriosis‐associated infertility: aspects of pathophysiological mechanisms and treatment options via openalex
- Familial Risk Among Patients with Endometriosis via openalex
- miR-92a promotes progesterone resistance in endometriosis through PTEN/AKT pathway via openalex
- The role of microRNAs in endometriosis and associated reproductive conditions via openalex
- Upregulated Circular RNA hsa_circ_0008433 Regulates Pathogenesis in Endometriosis Via miRNA via openalex
- World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research via openalex
- W2477066053 via openalex
- W1958284284 via openalex
- W1879876214 via openalex
- W2616533847 via openalex
- W2619780686 via openalex
- W2767548441 via openalex
- W2770021536 via openalex
- W2805276936 via openalex
- W2907177946 via openalex
- W2943404211 via openalex
- W1765516395 via openalex
- W6746725274 via openalex
- W2138664009 via openalex
- W6771776062 via openalex
- W2141417189 via openalex
- W2151922790 via openalex
- W1978337436 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-29T00:34:33.406613+00:00
License: CC0
· commercial use OK